Correlation Between Akari Therapeutics and RenovoRx

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both Akari Therapeutics and RenovoRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Akari Therapeutics and RenovoRx into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Akari Therapeutics PLC and RenovoRx, you can compare the effects of market volatilities on Akari Therapeutics and RenovoRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Akari Therapeutics with a short position of RenovoRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Akari Therapeutics and RenovoRx.

Diversification Opportunities for Akari Therapeutics and RenovoRx

-0.57
  Correlation Coefficient

Excellent diversification

The 3 months correlation between Akari and RenovoRx is -0.57. Overlapping area represents the amount of risk that can be diversified away by holding Akari Therapeutics PLC and RenovoRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on RenovoRx and Akari Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Akari Therapeutics PLC are associated (or correlated) with RenovoRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of RenovoRx has no effect on the direction of Akari Therapeutics i.e., Akari Therapeutics and RenovoRx go up and down completely randomly.

Pair Corralation between Akari Therapeutics and RenovoRx

Given the investment horizon of 90 days Akari Therapeutics PLC is expected to under-perform the RenovoRx. But the stock apears to be less risky and, when comparing its historical volatility, Akari Therapeutics PLC is 1.2 times less risky than RenovoRx. The stock trades about -0.03 of its potential returns per unit of risk. The RenovoRx is currently generating about 0.02 of returns per unit of risk over similar time horizon. If you would invest  210.00  in RenovoRx on September 4, 2024 and sell it today you would lose (90.00) from holding RenovoRx or give up 42.86% of portfolio value over 90 days.
Time Period3 Months [change]
DirectionMoves Against 
StrengthVery Weak
Accuracy99.8%
ValuesDaily Returns

Akari Therapeutics PLC  vs.  RenovoRx

 Performance 
       Timeline  
Akari Therapeutics PLC 

Risk-Adjusted Performance

0 of 100

 
Weak
 
Strong
Very Weak
Over the last 90 days Akari Therapeutics PLC has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of weak performance in the last few months, the Stock's basic indicators remain fairly strong which may send shares a bit higher in January 2025. The current disturbance may also be a sign of long term up-swing for the company investors.
RenovoRx 

Risk-Adjusted Performance

5 of 100

 
Weak
 
Strong
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in RenovoRx are ranked lower than 5 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively conflicting basic indicators, RenovoRx unveiled solid returns over the last few months and may actually be approaching a breakup point.

Akari Therapeutics and RenovoRx Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with Akari Therapeutics and RenovoRx

The main advantage of trading using opposite Akari Therapeutics and RenovoRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Akari Therapeutics position performs unexpectedly, RenovoRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in RenovoRx will offset losses from the drop in RenovoRx's long position.
The idea behind Akari Therapeutics PLC and RenovoRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Price Exposure Probability module to analyze equity upside and downside potential for a given time horizon across multiple markets.

Other Complementary Tools

Portfolio Comparator
Compare the composition, asset allocations and performance of any two portfolios in your account
Stocks Directory
Find actively traded stocks across global markets
Share Portfolio
Track or share privately all of your investments from the convenience of any device
Instant Ratings
Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance
Sign In To Macroaxis
Sign in to explore Macroaxis' wealth optimization platform and fintech modules